BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
There are thousands of aligned holes in Peru. Archaeologists now think they know who made them - 2What is the Insurrection Act? Can Trump really use the military to 'put an end' to Minneapolis ICE protests?
- 3Turkey’s intel chief lays out country’s vision for Middle East, world
- 4See the 'amazing' photos of Earth taken on historic Artemis II moon mission
- 5Cruising Solo All over the Planet: An Excursion of Self-Disclosure
- Taylor Swift just released the 'Elizabeth Taylor' music video — but she's not the star of it
- New Cheetos and Doritos will be free of artificial dyes
- 7 Powerful Techniques to Boost Efficiency with Your Cell Phone: A Far reaching Guide
- A company is trying to unlock a key to aging, in a long-overlooked body part
- Indonesian Mega-Farm Drives Surge in Deforestation
- Michael Jordan donates $10M to North Carolina medical center in honor of his mother
- Vote In favor of Your Favored Web-based Visual depiction Administration
- Fundamental Archives for Beginning Your Business
- James Webb Space Telescope discovers a lemon-shaped exoplanet unlike anything seen before: 'What the heck is this?'
